Figures & data
Figure 1. Schematic representation of methods to enable or facilitate TCI: (A) transfollicular delivery, (B) mechanical dermabrasion, (C) jet injection of liquids or powders, (D) microneedles (Images are not drawn to scale).
![Figure 1. Schematic representation of methods to enable or facilitate TCI: (A) transfollicular delivery, (B) mechanical dermabrasion, (C) jet injection of liquids or powders, (D) microneedles (Images are not drawn to scale).](/cms/asset/db40f81c-7583-418d-b8da-8faddb9fa6a0/khvi_a_10925217_f0001.gif)
Figure 2. Combinations of antigen and adjuvant in a particulate carrier: (A) adjuvants are co-administered with the encapsulated antigen, (B) antigen and adjuvant are encapsulated in separate particles, (C) antigen and adjuvant are co-encapsulated in the same particle, (D) the particle surface is decorated with the antigen and/or the adjuvant by physical or chemical association.
![Figure 2. Combinations of antigen and adjuvant in a particulate carrier: (A) adjuvants are co-administered with the encapsulated antigen, (B) antigen and adjuvant are encapsulated in separate particles, (C) antigen and adjuvant are co-encapsulated in the same particle, (D) the particle surface is decorated with the antigen and/or the adjuvant by physical or chemical association.](/cms/asset/ab408e26-7c6f-407d-a04a-1552bf69b27a/khvi_a_10925217_f0002.gif)